What is Preimplantation Genetics Diagnosis?
Pre-implantation genetic diagnosis (PGD) is a genetic analysis of the embryo that is performed by studying a biopsy of its cells prior to transfer to the mother's uterus. The high demand for PGD is to ensure that children are healthy and put an end to the transmission of a specific condition. PGD help to study the genetic diseases affecting a single gene and its use is not questioned. It is the only means of avoiding transmission of a genetic disorder without the partner having to face the possibility of the child she is carrying being affected and, therefore, having to face the decision of terminating the pregnancy.
The market study is broken down by Type (Instrument and Reagent), by Application (HLA Typing, Inheritable Genetic Disorders, Chromosomal Abnormalities, Single Gene Disorders, Gender Identification and Sex Linked Disorders) and major geographies with country level break-up.
The rising number of players in the global market is predicted to enhance the competition level as well as encourage the growth of the overall market in the near future. There are various companies that are operating in the new geographical regions by adopting various market growth initiatives such as mergers & acquisitions, expansions, investments, and others. Research Analyst at AMA estimates that Players from United States will contribute to the maximum growth of Global Preimplantation Genetics Diagnosis market throughout the predicted period.
Abbott Laboratories (United States), Natera, Inc (United States), Genea Limited (Australia), PerkinElmer, Inc. (United States), Illumina, Inc.(United States), F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (United States), Laboratory Corporation of America Holdings (United States), Agilent Technologies (United States), Quest Diagnostics Incorporated (United States), Cooper Surgical (United States) and Beijing Genomics Institute (BGI) (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Reproductive Genetics Institute (United States) and Reprogenetics LLC (United States).
AdvanceMarketAnalytics has segmented the market of Global Preimplantation Genetics Diagnosis market by Type, Application and Region.
On the basis of geography, the market of Preimplantation Genetics Diagnosis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Polymerase Chain Reaction (PCR) will boost the Preimplantation Genetics Diagnosis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospital will boost the Preimplantation Genetics Diagnosis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
In Jun 2020, Natera, Inc., a pioneer and global leader in cell-free DNA testing is pleased to announce the expansion of its laboratory facility in Austin, Texas, supporting greater test processing capacity.
In Oct 2018, Vitrolife AB (publ) has entered into a License and Commercialisation Agreement with Illumina, Inc., which provides Vitrolife with exclusive distribution, development, and commercialization rights to Illumina’s preimplantation genetic testing business for IVF in EMEA and Americas.
- Technological Advancements in the Field of Genetic Analysis
- Growing Demand for Non-invasive Biopsy Procedures in PGD
- Increasing Rate of Infertility
- Growing Awareness related to Genetic Techniques
- Surging R&D in Genetics by Key Players
- Improving Healthcare Infrastructure in Developing Countries
- Unfavorable Government Regulations associated with Preimplantation Genetic Diagnosis
Key Target AudienceVenture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Preimplantation Genetic Diagnosis Providers, Government Regulatory and Research Organizations and End-Use Industries
About ApproachDuring this study the evaluation and validation of the market size is done through various sources including primary and secondary analysis. AMA Research & Media follows industrial and regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase